Skip to content

Mary T. Zanda

3 papers in the library · publishing 2016-2019

Papers

Sort Most recent Most cited

The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats

Neuropharmacology 2019 Giulia Costa, Marcello Serra, Nicholas Pintori et al.

&NA; Methoxetamine (MXE) is a novel psychoactive substance that can induce several short‐term effects on emotional states and behavior. However, little is known about the persistent emotional and behavioral effects of MXE. Moreover, neurotoxic effects of MXE have been hypothesized, but never demonstrated in vivo. To clarify these issues, rats received repeated treatment with MXE every other day...

Methoxetamine affects brain processing involved in emotional response in rats.

British Journal of Pharmacology October 1, 2017 Mary T. Zanda, Paola Fadda, S Antinori et al.

Methoxetamine (MXE) is a novel psychoactive substance that is emerging on the Internet and induces dissociative effects and acute toxicity. Its pharmacological effects have not yet been adequately investigated. We examined a range of behavioural effects induced by acute administration of MXE (0.5-5 mg·kg-1 ; i.p.) in rats and whether it causes rapid neuroadaptive molecular changes. MXE (0.5-5...

Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings

Behavioural Pharmacology September 1, 2016 Mary T. Zanda, Paola Fadda, Cristiano Chiamulera et al.

An increasing number of novel psychoactive substances are currently available and sold as ‘legal highs’ or ‘research chemicals’ accompanied by the indication that they are ‘not for human consumption’. Among those that have emerged in the last few years, methoxetamine (MXE) owes its wide popularity to its easy access on the Internet and its reputation of being a ‘safe’ drug. MXE is an...